Taking AVONEX since 2005
Whatever your passion,
AVONEX helps protect it longer
;;At 2 years, people taking AVONEX were 37% less likely to have increased physical
disability, compared with people who weren’t treating their MS
;;In a separate 3-year study, people taking AVONEX were 44% less likely to have a
second flare-up, compared with people who weren’t treating their MSa
;;In the 10-year follow-up of the same 3-year study:
• People who started AVONEX early were 40% less likely to have a second flare-up,
compared with people who delayed treatmentb-d
• 8 out of 10 people taking AVONEX were still active in their daily lives at 10 years,
with EDSS scores below 3.0b,e
• 2 out of 3 people taking AVONEX had no cognitive decline on a test measuring memory,
attention, and mental processing speedb,f,g
;;Safety and efficacy of treatment with AVONEX beyond three years is not known
;; Talk to your doctor to find out if AVONEX is right for you
Call 1-800-456-2255 today to order
a free AVONEX information kit.
Focus on the future
a A 3-year study of people who had a first attack and lesions consistent with MS on their MRIs.
b A 10-year-follow-up of a 3-year study of people who had a first attack and lesions consistent with MS on their MRIs.
c People who started AVONEX early began treatment within 30 days of their first flare-up. People who delayed
treatment started AVONEX an average of 2.5 years after their first flare-up.
d This includes all people in this study at 10 years, regardless of whether they were taking AVONEX, another
therapy, or no therapy.
e The Expanded Disability Status Scale (EDSS) is a tool used by physicians to measure disability in people with MS.
f Between years 5 and 10 of the study.
g It is unknown whether the effects on cognition seen in this study were caused by AVONEX.